Antidepressant-like effect by postsynaptic 5-HT1A receptor activation in mice

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Serotonin (5-HT) pathways are implicated in mood regulation.
• Selective serotonin reuptake inhibitors (SSRIs) are common antidepressants.
• Novel compounds targeting specific serotonin receptors are being investigated for antidepressant potential.

Purpose of the Study:

• To investigate the antidepressant-like effect of 5-(3(-)[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy)-1,3- benzodioxole (MKC-242), a novel 5-HT1A receptor agonist.
• To determine the role of postsynaptic 5-HT1A receptors in the antidepressant-like activity of MKC-242.

Main Methods:

• The forced swimming test was used in mice to assess antidepressant-like behavior.
• Serotonin (5-HT) neurons were depleted using 5,7-dihydroxytryptamine (icv injection).
• Serotonin (5-HT) synthesis was inhibited using p-chlorophenylalanine.
• Locomotor activity was monitored to rule out non-specific effects.
• The effects of MKC-242 were evaluated in the presence of 5-HT1A receptor antagonists (propranolol and N-tert-butyl-3-(4-(2-methoxyphenyl)piperazin-1-yl)-2-phenylpropana mide).

Main Results:

• MKC-242 significantly reduced immobility time in the forced swimming test, indicating antidepressant-like effects.
• MKC-242 did not alter locomotor activity, suggesting a specific behavioral effect.
• The anti-immobility effect of MKC-242 was blocked by 5-HT1A receptor antagonists.
• These effects were observed even after depletion or inhibition of serotonin (5-HT) synthesis.

Conclusions:

• Postsynaptic 5-HT1A receptors are crucial for the antidepressant-like effect of MKC-242.
• MKC-242 represents a potential therapeutic agent for depression targeting the 5-HT1A receptor pathway.